NewEdge Advisors LLC Boosts Holdings in Oscar Health, Inc. $OSCR

Key Points

• NewEdge Advisors LLC increased its holdings in Oscar Health by 89.7%, owning 188,058 shares after purchasing an additional 88,946 shares during the first quarter.
• Oscar Health's stock has seen a recent revenue growth of 29% year-over-year, with quarterly revenue of $2.86 billion, although it reported a loss of ($0.89) EPS surpassing analysts' estimates of ($0.90).
• Multiple research firms have rated Oscar Health with a consensus "Strong Sell" and an average target price of $12.07, reflecting significant skepticism about its future performance.

NewEdge Advisors LLC increased its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 89.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 188,058 shares of the company's stock after purchasing an additional 88,946 shares during the period. NewEdge Advisors LLC owned 0.08% of Oscar Health worth $2,465,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Southeastern Asset Management Inc. TN raised its holdings in shares of Oscar Health by 52.2% during the 4th quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock worth $42,082,000 after acquiring an additional 1,073,359 shares in the last quarter. Man Group plc increased its position in shares of Oscar Health by 344.8% during the 4th quarter. Man Group plc now owns 1,813,216 shares of the company's stock valued at $24,370,000 after purchasing an additional 1,405,554 shares during the last quarter. Victory Capital Management Inc. increased its position in shares of Oscar Health by 23.8% during the 1st quarter. Victory Capital Management Inc. now owns 285,997 shares of the company's stock valued at $3,749,000 after purchasing an additional 54,938 shares during the last quarter. Toronto Dominion Bank bought a new position in shares of Oscar Health during the 4th quarter valued at approximately $1,008,000. Finally, Concurrent Investment Advisors LLC bought a new position in shares of Oscar Health during the 1st quarter valued at approximately $677,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Stock Performance

Shares of Oscar Health stock opened at $19.46 on Thursday. The stock's fifty day moving average is $15.81 and its two-hundred day moving average is $15.10. The company has a market capitalization of $5.03 billion, a PE ratio of -24.02 and a beta of 1.87. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The business had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. During the same quarter in the prior year, the company earned $0.20 EPS. The business's revenue was up 29.0% compared to the same quarter last year. As a group, analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on OSCR. Robert W. Baird reissued a "neutral" rating and set a $14.00 target price (down previously from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Wall Street Zen downgraded Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th. Raymond James Financial downgraded Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Wells Fargo & Company downgraded Oscar Health from an "equal weight" rating to an "underweight" rating and cut their price objective for the company from $16.00 to $10.00 in a research report on Friday, July 11th. Finally, UBS Group reaffirmed a "sell" rating and issued a $11.00 price objective (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Four equities research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. According to MarketBeat, Oscar Health currently has an average rating of "Strong Sell" and a consensus target price of $12.07.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.